NCT06550739View on ClinicalTrials.gov

Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients

CompletedOBSERVATIONAL
Enrollment

1,053

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

April 30, 2024

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

Randomization

Randomly divide the data into a training set and a validation set in a 7:3 ratio

Trial Locations (1)

Unknown

Chongqing University Cancer Hospital, Chongqing

All Listed Sponsors
lead

Haike Lei

OTHER

NCT06550739 - Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients | Biotech Hunter | Biotech Hunter